Neozyme International, Inc. Announces Large Order For NONTOX From Australian Agent
23 Février 2004 - 8:52PM
PR Newswire (US)
Neozyme International, Inc. Announces Large Order For NONTOX From
Australian Agent COSTA MESA, Calif., Feb. 23 /PRNewswire/ --
Neozyme International, Inc. (Neozyme), a subsidiary of
International Daleco Corporation , has received a NONTOX order
fromits Australian agent. The customer, a major real estate
development company, has several, on-site hydrocarbon remediation
compliance orders to resolve before construction can begin. Where
time of cleanup is financially important, Neozyme's patented NONTOX
bioorganic catalyst has proven to accelerate, at an incredible
rate, the biological breakdown of hydrocarbon contamination in both
soil and water. A controlled study for the U.S. Air Force,
completed in 1997, by a major U.S. engineering company, Metcalf
& Eddy, featured the use of NONTOX at a hydrocarbon remediation
site on a U.S. base. Concentrations of soluble petroleum were
reduced by 50% during a very convincing two-week trial period.
Neozyme manufactures and sells its patented line of bioorganic
catalytic formulations for numerous markets including, but not
limited to, municipal wastewater treatment, commercial/industrial,
hydrocarbon remediation, industrial metal cleaning and agriculture.
All Neozyme products are non-toxic, 100% biodegradable and can be
safely used around humans, animals, marine life, vegetation and the
environment. No special clothing or handling apparatus is required.
For more information, please visit http://www.neozyme.com/. This
News Release contains certain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934. These forward-looking
statements are based largely on the Company's expectations of
forecasts of futureevents, can be affected by inaccurate
assumptions and are subject to various risks and known and unknown
uncertainties, a number of which are beyond the Company's control.
Therefore, actual results could differ materially from the
forward-looking statements herein. DATASOURCE: International Daleco
Corporation CONTACT: Parker Dale, Chairman of International Daleco
Corporation, +1-949-515-1301, fax, +1-949-515-1314, Web site:
http://www.neozyme.com/
Copyright